ALBANY, N.Y., Nov. 30, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Medical Devices Conference in San Francisco, Calif., on Tuesday, December 6, 2011, at 10:40 a.m. Pacific Time. Joseph M. DeVivo, President and Chief Executive Officer of AngioDynamics, will review the Company's business strategy and recent corporate developments.
A live webcast and subsequent archived replay of AngioDynamics' presentation may be accessed via the investor relations section of the Company's Web site under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.AngioDynamics.com.
CONTACT: Company Contact:
AngioDynamics, Inc.D. Joseph Gersuk, CFO
(800) 772-6446 x1608
jgersuk@AngioDynamics.com
Investor Relations Contacts:
EVC Group, Inc.Doug Sherk/ Greg Gin
(415) 568-4887; (646) 445-4801
dsherk@evcgroup.com; ggin@evcgroup.com
Media Contact:
EVC Group, Inc.Chris Gale
(646) 201-5431
cgale@evcgroup.com
Source:
AngioDynamics
News Provided by Acquire Media